| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 20 | 2022 | 641 | 1.570 |
Why?
|
| Glucose | 20 | 2023 | 876 | 1.060 |
Why?
|
| Adipocytes, Brown | 2 | 2021 | 25 | 0.870 |
Why?
|
| Liver | 17 | 2023 | 1747 | 0.680 |
Why?
|
| Obesity | 16 | 2022 | 2244 | 0.620 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 365 | 0.570 |
Why?
|
| Vibrio cholerae | 11 | 1999 | 26 | 0.560 |
Why?
|
| Mice | 50 | 2023 | 17711 | 0.540 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2015 | 137 | 0.530 |
Why?
|
| MicroRNAs | 2 | 2020 | 858 | 0.520 |
Why?
|
| Adipose Tissue, White | 9 | 2021 | 76 | 0.520 |
Why?
|
| Adipose Tissue | 6 | 2020 | 465 | 0.500 |
Why?
|
| Hyperglycemia | 6 | 2021 | 227 | 0.490 |
Why?
|
| Hypoglycemic Agents | 4 | 2022 | 443 | 0.460 |
Why?
|
| Gene Expression Regulation | 13 | 2023 | 2525 | 0.440 |
Why?
|
| Animals | 56 | 2023 | 34205 | 0.430 |
Why?
|
| Blood Glucose | 7 | 2021 | 1133 | 0.420 |
Why?
|
| Fatty Acids | 5 | 2023 | 344 | 0.410 |
Why?
|
| Diet, High-Fat | 8 | 2022 | 209 | 0.390 |
Why?
|
| Mice, Knockout | 21 | 2021 | 3753 | 0.380 |
Why?
|
| STAT1 Transcription Factor | 3 | 2020 | 73 | 0.370 |
Why?
|
| Adipocytes, White | 3 | 2021 | 24 | 0.370 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 403 | 0.360 |
Why?
|
| Oleanolic Acid | 1 | 2010 | 6 | 0.350 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2017 | 376 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 21 | 2022 | 4415 | 0.340 |
Why?
|
| Insulin | 10 | 2022 | 1203 | 0.340 |
Why?
|
| Insulin-Secreting Cells | 4 | 2021 | 148 | 0.340 |
Why?
|
| Peptide Hormones | 3 | 2017 | 68 | 0.320 |
Why?
|
| Fasting | 5 | 2023 | 293 | 0.300 |
Why?
|
| Perilipin-2 | 3 | 2017 | 10 | 0.300 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 489 | 0.300 |
Why?
|
| Signal Transduction | 9 | 2021 | 4595 | 0.280 |
Why?
|
| Cells, Cultured | 10 | 2021 | 3017 | 0.280 |
Why?
|
| Gene Deletion | 4 | 2021 | 792 | 0.270 |
Why?
|
| Energy Metabolism | 9 | 2021 | 765 | 0.260 |
Why?
|
| Adipose Tissue, Brown | 5 | 2021 | 73 | 0.250 |
Why?
|
| Phosphoproteins | 2 | 2004 | 419 | 0.240 |
Why?
|
| Lipolysis | 2 | 2004 | 79 | 0.230 |
Why?
|
| Microfilament Proteins | 2 | 2017 | 278 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2022 | 1273 | 0.230 |
Why?
|
| Homeostasis | 7 | 2021 | 704 | 0.230 |
Why?
|
| Inflammation | 3 | 2020 | 1447 | 0.230 |
Why?
|
| Diet | 2 | 2010 | 1138 | 0.220 |
Why?
|
| Hyperinsulinism | 2 | 2021 | 67 | 0.220 |
Why?
|
| Thermogenesis | 3 | 2021 | 45 | 0.220 |
Why?
|
| Cytotoxins | 3 | 1999 | 22 | 0.220 |
Why?
|
| Muscle, Skeletal | 3 | 2010 | 945 | 0.210 |
Why?
|
| Carrier Proteins | 5 | 2021 | 1027 | 0.210 |
Why?
|
| Fatty Liver | 3 | 2010 | 190 | 0.210 |
Why?
|
| Leptin | 5 | 2021 | 213 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2017 | 781 | 0.200 |
Why?
|
| Insulins | 1 | 2022 | 17 | 0.200 |
Why?
|
| Diabetic Nephropathies | 1 | 2023 | 110 | 0.200 |
Why?
|
| Hepatocytes | 8 | 2017 | 210 | 0.190 |
Why?
|
| PPAR alpha | 2 | 2023 | 51 | 0.190 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2022 | 51 | 0.190 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2021 | 23 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 22 | 0.190 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 25 | 0.190 |
Why?
|
| Cholera | 6 | 1999 | 25 | 0.190 |
Why?
|
| PPAR gamma | 2 | 2020 | 88 | 0.190 |
Why?
|
| Glucose Tolerance Test | 5 | 2021 | 208 | 0.190 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2021 | 36 | 0.190 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 13 | 0.180 |
Why?
|
| Osteocalcin | 1 | 2021 | 42 | 0.180 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2021 | 27 | 0.180 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2021 | 31 | 0.180 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2021 | 16 | 0.180 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 107 | 0.180 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2021 | 38 | 0.180 |
Why?
|
| Lipodystrophy | 1 | 2021 | 33 | 0.180 |
Why?
|
| Haloferax | 1 | 2020 | 1 | 0.180 |
Why?
|
| CD11c Antigen | 1 | 2020 | 38 | 0.170 |
Why?
|
| Organelle Biogenesis | 1 | 2020 | 16 | 0.170 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2020 | 68 | 0.170 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2020 | 30 | 0.170 |
Why?
|
| Neurons | 3 | 2021 | 1931 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2020 | 116 | 0.170 |
Why?
|
| Hypothalamus | 2 | 2021 | 211 | 0.170 |
Why?
|
| Copper-transporting ATPases | 1 | 2020 | 23 | 0.170 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 4405 | 0.160 |
Why?
|
| Autophagy | 3 | 2017 | 395 | 0.160 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2020 | 33 | 0.160 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2017 | 120 | 0.160 |
Why?
|
| Patched-1 Receptor | 1 | 2019 | 44 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 261 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2011 | 163 | 0.160 |
Why?
|
| Pituitary Gland | 1 | 2019 | 82 | 0.160 |
Why?
|
| Transcription Factors | 5 | 2023 | 2603 | 0.150 |
Why?
|
| Pyruvic Acid | 1 | 2018 | 38 | 0.150 |
Why?
|
| Mice, Obese | 6 | 2022 | 71 | 0.150 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2011 | 201 | 0.150 |
Why?
|
| Integrases | 1 | 2019 | 160 | 0.150 |
Why?
|
| Subcutaneous Fat | 1 | 2018 | 29 | 0.150 |
Why?
|
| Adipogenesis | 2 | 2009 | 72 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2021 | 505 | 0.140 |
Why?
|
| Fibroma | 1 | 2018 | 30 | 0.140 |
Why?
|
| Oxidation-Reduction | 5 | 2023 | 442 | 0.140 |
Why?
|
| Ossification, Heterotopic | 1 | 2018 | 41 | 0.140 |
Why?
|
| Liver X Receptors | 1 | 2017 | 18 | 0.140 |
Why?
|
| Gene Products, vpr | 1 | 2017 | 20 | 0.140 |
Why?
|
| Adaptation, Physiological | 2 | 2013 | 268 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2017 | 7 | 0.140 |
Why?
|
| Mitochondria | 2 | 2021 | 677 | 0.140 |
Why?
|
| Appetite Regulation | 1 | 2017 | 41 | 0.140 |
Why?
|
| Islets of Langerhans | 3 | 2017 | 174 | 0.140 |
Why?
|
| Metaplasia | 1 | 2018 | 213 | 0.140 |
Why?
|
| Triglycerides | 4 | 2017 | 571 | 0.130 |
Why?
|
| Metabolomics | 1 | 2020 | 422 | 0.130 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 62 | 0.130 |
Why?
|
| Eating | 2 | 2015 | 366 | 0.120 |
Why?
|
| Male | 26 | 2021 | 61429 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 25 | 0.120 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 414 | 0.120 |
Why?
|
| Proinsulin | 1 | 2015 | 12 | 0.120 |
Why?
|
| Hypogonadism | 1 | 2019 | 296 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 1996 | 176 | 0.120 |
Why?
|
| Humans | 36 | 2022 | 125025 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2012 | 801 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 873 | 0.120 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2017 | 136 | 0.120 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 2413 | 0.120 |
Why?
|
| Receptors, LDL | 1 | 2015 | 88 | 0.120 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2015 | 78 | 0.120 |
Why?
|
| Circadian Rhythm | 2 | 2016 | 274 | 0.120 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2014 | 5 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 1273 | 0.120 |
Why?
|
| Gluconeogenesis | 3 | 2010 | 106 | 0.110 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2014 | 28 | 0.110 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2015 | 83 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 136 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 420 | 0.110 |
Why?
|
| HIV-1 | 1 | 2017 | 464 | 0.110 |
Why?
|
| Lipids | 3 | 2007 | 519 | 0.110 |
Why?
|
| India | 8 | 2020 | 211 | 0.110 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 39 | 0.100 |
Why?
|
| Estrogens | 1 | 2015 | 503 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 385 | 0.100 |
Why?
|
| Adipocytes | 2 | 2020 | 141 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 453 | 0.100 |
Why?
|
| Dietary Fats | 2 | 2011 | 292 | 0.090 |
Why?
|
| Female | 19 | 2022 | 66669 | 0.090 |
Why?
|
| Peptidomimetics | 1 | 2011 | 12 | 0.090 |
Why?
|
| Receptors, Ghrelin | 1 | 2011 | 28 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2021 | 318 | 0.090 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2012 | 105 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 626 | 0.090 |
Why?
|
| HeLa Cells | 7 | 2006 | 788 | 0.090 |
Why?
|
| Lipid Metabolism | 4 | 2017 | 356 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 1021 | 0.090 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2010 | 17 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2015 | 687 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2023 | 177 | 0.090 |
Why?
|
| Cytokines | 1 | 1996 | 1292 | 0.090 |
Why?
|
| Glucose-6-Phosphate | 1 | 2010 | 3 | 0.090 |
Why?
|
| Lipoproteins, VLDL | 1 | 2010 | 57 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2020 | 1109 | 0.080 |
Why?
|
| RNA Interference | 3 | 2020 | 507 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2011 | 1633 | 0.080 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2010 | 238 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 190 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1550 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 623 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2010 | 191 | 0.080 |
Why?
|
| Aging | 2 | 2017 | 1180 | 0.080 |
Why?
|
| Cholera Toxin | 3 | 1999 | 49 | 0.080 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2008 | 18 | 0.080 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 11 | 0.080 |
Why?
|
| Kidney | 5 | 2023 | 1353 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2021 | 737 | 0.080 |
Why?
|
| Disease Outbreaks | 4 | 1999 | 320 | 0.080 |
Why?
|
| COUP Transcription Factor II | 1 | 2009 | 116 | 0.070 |
Why?
|
| Weight Loss | 1 | 2011 | 481 | 0.070 |
Why?
|
| Perilipin-1 | 2 | 2004 | 7 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2013 | 818 | 0.070 |
Why?
|
| Apoptosis | 3 | 2017 | 1819 | 0.070 |
Why?
|
| Uncoupling Protein 1 | 2 | 2021 | 26 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 161 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2010 | 874 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2008 | 92 | 0.070 |
Why?
|
| Fibrillin-1 | 2 | 2017 | 59 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 963 | 0.070 |
Why?
|
| Protein Binding | 2 | 2021 | 1747 | 0.060 |
Why?
|
| Ovary | 2 | 2019 | 374 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 560 | 0.060 |
Why?
|
| HIV Infections | 1 | 2017 | 1896 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 225 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 368 | 0.060 |
Why?
|
| Cholesterol | 1 | 2008 | 540 | 0.060 |
Why?
|
| Ion Channels | 3 | 2013 | 191 | 0.060 |
Why?
|
| Culture Media | 3 | 2020 | 180 | 0.060 |
Why?
|
| Mitochondrial Proteins | 3 | 2013 | 228 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2021 | 381 | 0.060 |
Why?
|
| Cell Line | 3 | 2017 | 2717 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2004 | 102 | 0.050 |
Why?
|
| Intestinal Mucosa | 2 | 1999 | 781 | 0.050 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 7 | 0.050 |
Why?
|
| Flavoproteins | 1 | 2023 | 16 | 0.050 |
Why?
|
| Biological Transport | 2 | 2018 | 352 | 0.050 |
Why?
|
| Auranofin | 1 | 2022 | 3 | 0.050 |
Why?
|
| Sugars | 1 | 2022 | 15 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 2709 | 0.050 |
Why?
|
| Depressive Disorder, Major | 1 | 2008 | 402 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1538 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3422 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 670 | 0.050 |
Why?
|
| Hydroxylation | 1 | 2021 | 48 | 0.050 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2021 | 31 | 0.050 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2002 | 109 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 96 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 79 | 0.050 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 89 | 0.050 |
Why?
|
| Carnitine | 1 | 2021 | 74 | 0.050 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 92 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 40 | 0.040 |
Why?
|
| Body Temperature | 1 | 2021 | 117 | 0.040 |
Why?
|
| Emulsifying Agents | 1 | 2020 | 2 | 0.040 |
Why?
|
| Batch Cell Culture Techniques | 1 | 2020 | 6 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2020 | 43 | 0.040 |
Why?
|
| Biopolymers | 1 | 2020 | 20 | 0.040 |
Why?
|
| Rheology | 1 | 2020 | 33 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 283 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 25 | 0.040 |
Why?
|
| Virulence | 2 | 1999 | 265 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 812 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2020 | 51 | 0.040 |
Why?
|
| Adipokines | 1 | 2021 | 60 | 0.040 |
Why?
|
| Galactose | 1 | 2020 | 54 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2002 | 252 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 150 | 0.040 |
Why?
|
| Uncoupling Protein 2 | 2 | 2013 | 13 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 78 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2020 | 136 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 386 | 0.040 |
Why?
|
| Shigella flexneri | 1 | 1999 | 13 | 0.040 |
Why?
|
| Calcium | 2 | 2022 | 1099 | 0.040 |
Why?
|
| Salmonella Infections | 1 | 1999 | 31 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2019 | 21 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2019 | 56 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2019 | 47 | 0.040 |
Why?
|
| CHO Cells | 2 | 1996 | 163 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 55 | 0.040 |
Why?
|
| Ghrelin | 2 | 2011 | 52 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 296 | 0.040 |
Why?
|
| Cricetinae | 2 | 1996 | 396 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2016 | 3889 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2018 | 31 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 493 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 1999 | 169 | 0.040 |
Why?
|
| Plasmids | 1 | 1999 | 511 | 0.040 |
Why?
|
| Placenta | 1 | 2022 | 507 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 686 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2020 | 801 | 0.040 |
Why?
|
| Ileum | 1 | 1999 | 134 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 61 | 0.040 |
Why?
|
| Body Composition | 1 | 2021 | 521 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2020 | 505 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 1998 | 998 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 2015 | 695 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1294 | 0.040 |
Why?
|
| Appetite Depressants | 1 | 2017 | 22 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 187 | 0.040 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 88 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 2055 | 0.040 |
Why?
|
| NIH 3T3 Cells | 2 | 2008 | 92 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2017 | 100 | 0.040 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2017 | 13 | 0.030 |
Why?
|
| Glutamine | 1 | 2018 | 215 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 29452 | 0.030 |
Why?
|
| Sterol Esterase | 1 | 2017 | 19 | 0.030 |
Why?
|
| Metabolome | 1 | 2020 | 293 | 0.030 |
Why?
|
| Tunicamycin | 1 | 2017 | 7 | 0.030 |
Why?
|
| Testis | 1 | 2019 | 410 | 0.030 |
Why?
|
| Reproduction | 1 | 2019 | 236 | 0.030 |
Why?
|
| Oleic Acid | 1 | 2017 | 16 | 0.030 |
Why?
|
| Enterobacteriaceae | 1 | 1997 | 32 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1701 | 0.030 |
Why?
|
| Proteins | 1 | 2002 | 1037 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 1757 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2010 | 2813 | 0.030 |
Why?
|
| Immunodiffusion | 1 | 1996 | 22 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 1996 | 35 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 641 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 486 | 0.030 |
Why?
|
| Progeria | 1 | 2016 | 16 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 438 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 382 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1996 | 308 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 244 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 158 | 0.030 |
Why?
|
| Body Weight | 2 | 2012 | 989 | 0.030 |
Why?
|
| Phenols | 1 | 2015 | 53 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 567 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 1017 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 825 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 175 | 0.030 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2014 | 4 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 1337 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 367 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 619 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 178 | 0.030 |
Why?
|
| Dependovirus | 1 | 2015 | 128 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 238 | 0.030 |
Why?
|
| Testosterone | 1 | 2019 | 558 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 887 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2377 | 0.030 |
Why?
|
| Middle Aged | 4 | 2021 | 26670 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 306 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 1399 | 0.020 |
Why?
|
| Laser Capture Microdissection | 1 | 2012 | 7 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 681 | 0.020 |
Why?
|
| Cercopithecidae | 1 | 2011 | 7 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2012 | 147 | 0.020 |
Why?
|
| Phenotype | 3 | 2008 | 4266 | 0.020 |
Why?
|
| Diarrhea | 1 | 1993 | 315 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 130 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 178 | 0.020 |
Why?
|
| Anthropometry | 1 | 2011 | 197 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 3723 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1984 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 1708 | 0.020 |
Why?
|
| Models, Biological | 2 | 2006 | 1461 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2011 | 30 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 86 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 2011 | 36 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 258 | 0.020 |
Why?
|
| Perilipin-3 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Phosphofructokinase-1 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 355 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 199 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 239 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2010 | 33 | 0.020 |
Why?
|
| Phosphofructokinase-2 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 190 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 190 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7215 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 495 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 2012 | 310 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2009 | 27 | 0.020 |
Why?
|
| Glycolysis | 1 | 2010 | 152 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2009 | 56 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2008 | 19 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2009 | 50 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 653 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2008 | 23 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 96 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 100 | 0.020 |
Why?
|
| Mutation | 2 | 1999 | 5897 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2011 | 244 | 0.020 |
Why?
|
| Methylation | 1 | 2008 | 224 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 635 | 0.020 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2008 | 72 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1684 | 0.020 |
Why?
|
| Rabbits | 2 | 1999 | 714 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2009 | 216 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 256 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2008 | 103 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 6296 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 2 | 1999 | 99 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1591 | 0.020 |
Why?
|
| Birth Weight | 1 | 2008 | 346 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 577 | 0.020 |
Why?
|
| Heterozygote | 1 | 2009 | 672 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 19 | 0.020 |
Why?
|
| Cholic Acid | 1 | 2006 | 18 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2006 | 43 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2006 | 38 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 960 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 375 | 0.020 |
Why?
|
| Prevalence | 2 | 2008 | 2458 | 0.020 |
Why?
|
| Muscles | 1 | 2006 | 291 | 0.020 |
Why?
|
| Adolescent | 3 | 2017 | 19412 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2005 | 38 | 0.020 |
Why?
|
| Pancreas | 1 | 2006 | 220 | 0.010 |
Why?
|
| Peptide Library | 1 | 2004 | 57 | 0.010 |
Why?
|
| Electron Transport | 1 | 2003 | 55 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 573 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 692 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9054 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 2003 | 47 | 0.010 |
Why?
|
| Immunogenetics | 1 | 2002 | 8 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 2002 | 21 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2002 | 77 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2002 | 113 | 0.010 |
Why?
|
| Adiponectin | 1 | 2002 | 113 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 794 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1908 | 0.010 |
Why?
|
| Risk Factors | 2 | 2008 | 10278 | 0.010 |
Why?
|
| Haplotypes | 1 | 2002 | 520 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 1033 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3597 | 0.010 |
Why?
|
| Phospholipases | 1 | 1999 | 7 | 0.010 |
Why?
|
| Acetophenones | 1 | 1999 | 13 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2002 | 217 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1999 | 166 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1999 | 30 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 3402 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 1999 | 101 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 827 | 0.010 |
Why?
|
| Tight Junctions | 1 | 1999 | 39 | 0.010 |
Why?
|
| Body Water | 1 | 1999 | 89 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1999 | 82 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 1425 | 0.010 |
Why?
|
| Caseins | 1 | 1998 | 64 | 0.010 |
Why?
|
| Hemolysis | 1 | 1999 | 111 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 201 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1998 | 116 | 0.010 |
Why?
|
| Genome, Bacterial | 1 | 1999 | 183 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 1021 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 1614 | 0.010 |
Why?
|
| Child | 2 | 2015 | 24609 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1999 | 307 | 0.010 |
Why?
|
| Actins | 1 | 1999 | 338 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 968 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 587 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 780 | 0.010 |
Why?
|
| Intestines | 1 | 1999 | 577 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 303 | 0.010 |
Why?
|
| Bangladesh | 1 | 1993 | 21 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1993 | 69 | 0.010 |
Why?
|
| Electrolytes | 1 | 1993 | 53 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 5167 | 0.010 |
Why?
|
| Hematocrit | 1 | 1993 | 114 | 0.010 |
Why?
|
| Genotype | 1 | 1999 | 2569 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3175 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 6535 | 0.010 |
Why?
|
| Aged | 2 | 2002 | 19653 | 0.010 |
Why?
|
| Acute Disease | 1 | 1993 | 1095 | 0.010 |
Why?
|
| Feces | 1 | 1993 | 727 | 0.010 |
Why?
|
| Infant | 1 | 1993 | 12610 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1993 | 14150 | 0.000 |
Why?
|